Paul Burden

ADVANZ PHARMA Corp. Ltd. is a pharmaceutical company engages in the provision of branded and unbranded products. The firm specializes in anti-Infectives and endocrinology therapy areas. It operates through the following segments: Advanz Pharma International; Advanz Pharma North America; and Corporate. The Advanz Pharma International segment include portfolio of branded and generic products that are sold to wholesalers, hospitals, and pharmacies. The Advanz Pharma North America segment comprises branded products and authorized generic contracts that focuses primarily on the U.S. pharmaceutical market. The Corporate segment represents the centralized costs. The company was founded by Mark L. Thompson on January 20, 2010 and is headquartered in St. Helier, the United Kingdom.

Part of Teva Pharmaceutical Industries Ltd., Teva UK Ltd. is a pharmaceutical company that provides medicines to improve the health of millions of patients every day. Teva offers generic, biosimilar, and specialty medicines to help patients take control of their health and help the NHS make the most of its limited resources. The company was founded in 1935 by Nora Sarsby and Margaret Galloway and is based in Castleford, UK. Teva believes in enforcing strong practices and controls to ensure all activities are carried out ethically and transparently. The British company works with governments and customs authorities to control the problems caused by counterfeit medicines.

Fleishman-Hillard Canada, Inc. operates a strategic communications and public affairs company in Canada. It offers services in various areas, including business-to-consumer, business-to-government, corporate social responsibility, crisis communications, digital and social media, financial communications, government relations, internal communications, labor communications, litigation communications, media and presentation training, public affairs, reputation management, and research. The company was founded in 1986 and is headquartered in Ottawa, Canada.